Portable Nanoplasmonic Imager Detects Sepsis Faster
By HospiMedica International staff writers Posted on 05 Feb 2020 |

Image: A nano-scale optical biosensor can rapidly detect sepsis (Photo courtesy of EPFL)
A highly portable device based on a nano-scale optical biosensor can rapidly detect inflammatory biomarkers in a patient's bloodstream.
Developed at Ecole Polytechnique Fédérale de Lausanne (EPFL; Switzerland), Hospital Universitari Vall dHebron (Barcelona, Spain), and Universitat Autònoma de Barcelona (UAB, Spain), the new device employs a gold-based metasurface that concentrates light around billions of nanoholes. Nanoparticles that capture the sepsis biomarkers procalcitonin (PCT) and C‐reactive protein (CRP) are distributed on the metasurface, and those that have captured biomarkers are trapped in the nanoholes. When an LED is applied, they partially obstruct the light passing through the perforated metasurface, allowing detection with a CMOS camera.
In field studies with a wide range of patient samples with sepsis, noninfectious systemic inflammatory response syndrome (SIRS), and healthy subjects, the device achieves an outstanding limit of detection of 21.3 pg mL−1 for PCT and 36 pg mL−1 for CRP. The results were validated against clinical diagnosis and currently used immunoassays, providing a performance level equivalent to the gold‐standard laboratory tests. Importantly, the plasmonic imager can enable identification of PCT levels typical of sepsis and SIRS patients in less than 15 minutes. The study was published on January 23, 2020, in Small.
“The device proved to be particularly suitable for on‐site operation due to its portability, inexpensive off‐the‐shelf optical components, and because it does not involve any moving parts or complex microfluidic elements prone to clogging,” concluded lead author Alexander Belushkin, PhD, of the EPFL Institute of BioEngineering, and colleagues. “Importantly, the sensor chips and bioassay reagents can be stored in the fridge stably over weeks and unlike previously reported optical detection schemes, do not require fluorescent tags that can be expensive, unstable, and difficult to produce.”
Sepsis is the primary cause of death in hospitals, and one of the ten leading causes of death worldwide, claiming a life every four seconds. It is associated with the body's inflammatory response to a bacterial infection and progresses extremely rapidly: every hour that goes by before it is properly diagnosed and treated increases the mortality rate by nearly 8%. Time is critical with sepsis, but the tests currently used in hospitals can take up to 72 hours to provide a diagnosis.
Related Links:
Ecole Polytechnique Fédérale de Lausanne
Hospital Universitari Vall dHebron
Universitat Autònoma de Barcelona
Developed at Ecole Polytechnique Fédérale de Lausanne (EPFL; Switzerland), Hospital Universitari Vall dHebron (Barcelona, Spain), and Universitat Autònoma de Barcelona (UAB, Spain), the new device employs a gold-based metasurface that concentrates light around billions of nanoholes. Nanoparticles that capture the sepsis biomarkers procalcitonin (PCT) and C‐reactive protein (CRP) are distributed on the metasurface, and those that have captured biomarkers are trapped in the nanoholes. When an LED is applied, they partially obstruct the light passing through the perforated metasurface, allowing detection with a CMOS camera.
In field studies with a wide range of patient samples with sepsis, noninfectious systemic inflammatory response syndrome (SIRS), and healthy subjects, the device achieves an outstanding limit of detection of 21.3 pg mL−1 for PCT and 36 pg mL−1 for CRP. The results were validated against clinical diagnosis and currently used immunoassays, providing a performance level equivalent to the gold‐standard laboratory tests. Importantly, the plasmonic imager can enable identification of PCT levels typical of sepsis and SIRS patients in less than 15 minutes. The study was published on January 23, 2020, in Small.
“The device proved to be particularly suitable for on‐site operation due to its portability, inexpensive off‐the‐shelf optical components, and because it does not involve any moving parts or complex microfluidic elements prone to clogging,” concluded lead author Alexander Belushkin, PhD, of the EPFL Institute of BioEngineering, and colleagues. “Importantly, the sensor chips and bioassay reagents can be stored in the fridge stably over weeks and unlike previously reported optical detection schemes, do not require fluorescent tags that can be expensive, unstable, and difficult to produce.”
Sepsis is the primary cause of death in hospitals, and one of the ten leading causes of death worldwide, claiming a life every four seconds. It is associated with the body's inflammatory response to a bacterial infection and progresses extremely rapidly: every hour that goes by before it is properly diagnosed and treated increases the mortality rate by nearly 8%. Time is critical with sepsis, but the tests currently used in hospitals can take up to 72 hours to provide a diagnosis.
Related Links:
Ecole Polytechnique Fédérale de Lausanne
Hospital Universitari Vall dHebron
Universitat Autònoma de Barcelona
Latest Critical Care News
- AI-Enhanced Echocardiography Improves Early Detection of Amyloid Buildup in Heart
- Consumer Wearables Could Predict Pediatric Surgery Complications
- Wireless Implant Delivers Chemotherapy Deep into Tumors Without Side Effects
- Skin-Like Sensor Monitors Vital Signs and Tracks Healing After Surgery
- Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
- New Prostate Screening Device Could Replace Traditional Examination Method
- Adaptive Spine Board to Revolutionize ER Transport
- Mapping Communication Between Internal Organs to Enable Earlier Illness Diagnosis
- Intelligent Wound Dressing Reduces Inflammation and Promotes Healing
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
Channels
Critical Care
view channel
AI-Enhanced Echocardiography Improves Early Detection of Amyloid Buildup in Heart
Cardiac amyloidosis is a life-threatening condition where an abnormal protein called amyloid builds up in the heart, causing it to stiffen and lose functionality. The disease is often missed because its... Read more
Consumer Wearables Could Predict Pediatric Surgery Complications
An estimated 4 million children undergo surgical procedures in U.S. hospitals each year. Postoperative complications, such as infections, can pose significant health risks to children, and timely detection... Read moreSurgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more